The Wesfarmers Ltd (ASX: WES) share price has just capped off its second year of stunning gains. But here's why I'm not ...
I believe both of these ASX exchange-traded funds (ETFs) are well-positioned to deliver solid returns this year. Here’s why.
Bell Potter has a buy rating and $34.00 price target on its shares. This suggests that upside of 20% is possible from current levels. Goldman Sachs has just initiated coverage on ResMed and named it ...